AMA, which target the PDC-E2, are found in over 90% of PBC patients, making them a highly sensitive indicator of the disease [54]; however, AMA reactivity alone is not sufficient for a definitive PBC diagnosis. This evidence concerns the gene DLAT and primary biliary cholangitis.